Day: April 28, 2025

New York, N.Y., April 28, 2025 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced that on Thursday, April 24, 2025, a Las Vegas judge granted in full two motions to dismiss brought by NANO Nuclear Energy Inc. and its officers and directors in a putative shareholder derivative action entitled Latza v. Walker, et al., Case No. A-24-900423-B, Clark County, Nevada District Court. “We are extremely pleased that this case has been so promptly adjudicated and dismissed in its entirety,” said Jay Yu, Founder and Chairman of NANO Nuclear. “This ruling will allow us to devote more of our time and attention to NANO Nuclear’s primary mission of becoming the leading commercially focused...

CHICAGO and VANCOUVER, British Columbia, April 28, 2025 (GLOBE NEWSWIRE) — RISE Dispensaries, a rapidly growing cannabis retail chain owned by Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), today announced that RISE Dispensary Ocala, the Company’s 22nd retail location in Florida and 104th nationwide, will open on April 29. Located at 3873 SW College Road, the dispensary will offer medical patients a diverse collection of cannabis products from brands including RYTHM, Dogwalkers, &Shine, Good Green, and Doctor Solomon’s. As part of RISE and Green Thumb’s ongoing commitment to supporting local communities, RISE Dispensary Ocala will donate a portion of one day’s profits to community-based organization The Bridge 4 Veterans. “We are thrilled to open our first RISE Dispensary in...

VYJUVEK approved for the treatment of DEB from birth in Europe Approval allows for dosing at home or in a healthcare setting, as well as patient or caregiver administration if deemed appropriate by a healthcare professional PITTSBURGH, April 28, 2025 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that on April 23, 2025, the European Commission (EC) granted marketing authorization to VYJUVEK® (beremagene geperpavec-svdt) for the treatment of wounds in patients with dystrophic epidermolysis bullosa (DEB) who have mutations in the collagen type VII alpha 1 chain (COL7A1) gene, starting from birth. VYJUVEK is designed to address the genetic root cause of DEB by delivering functional copies of the human COL7A1 gene to provide wound healing and sustained functional type VII collagen protein expression...

TORONTO, April 28, 2025 (GLOBE NEWSWIRE) — Matador Technologies Inc. (“Matador” or the “Company”) (TSXV: MATA, OTCQB: MATAF), a Bitcoin Ecosystem company, is pleased to announce that the Company’s stock ticker symbol on the OTCQB Venture Market (the “OTCQB”) will change from “MTDTF” to “MATAF” effective as of market open on Monday, April 28, 2025. As a result of this change, “MATAF” will now be the ticker symbol for Matador’s common shares listed on the OTCQB. The change allows for improved and synchronized brand alignment for the stock and the Company. No action is required by Matador’s shareholders in connection with the ticker symbol change. Matador is also pleased to announce that its common shares, traded in the United States under the symbol “MATAF” on the OTCQB, are now eligible for electronic clearing and settlement through...

TORONTO, April 28, 2025 (GLOBE NEWSWIRE) — Clear Blue Technologies International Inc. (TSXV: CBLU) the Smart Off-Grid™ Company, today announces that it will provide a corporate update and also report financial results for its fiscal 2024 on Wednesday, April 30, 2025, after the market closes. Welcome to Clear Blue 2.0! Clear Blue has successfully completed its financial restructuring and is now positioned to move forward and execute on the opportunity ahead. The Company has been very busy. Clear Blue will host a conference call on Thursday, May 1st, at 11:00 a.m. Eastern Time, to review the financial restructuring, the Company’s 2024 results, and to provide an update on its 2025 outlook and growth plan going forward. Those interested can register at: Registration Link https://us06web.zoom.us/webinar/register/WN_yLCwKEZnTLKhrAlYtqG51g Final...

Awards Spotlight Village Farms International’s Visionary Leadership, Global Growth, and Commitment to Sustainable InnovationVANCOUVER, British Columbia, April 28, 2025 (GLOBE NEWSWIRE) — Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) was named the winner of two Gold Stevie® Awards and one Bronze Stevie® Award in the 23rd Annual American Business Awards®. The company earned top honors in the categories of Sustainable Business Models and Lifetime Achievement – Consumer Products Industries for Founder, President and Chief Executive Officer Michael A. DeGiglio, along with a Bronze in Achievement in International Expansion. The American Business Awards® are the U.S.A.’s premier business awards program. All organizations operating in the U.S.A. are eligible to submit nominations – public and...

Data presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 Dose Finding completed with no dose limiting toxicities and preliminary recommended Phase 2 dose (RP2D) identified 5 of 7 best overall response evaluable patients achieved ORR (3 CR, 1 CRh and 1 morphologic leukemia-free state) across all dose cohorts, including 1 CR and 1 CRh in 3 patients in preliminary RP2D cohort 4 of 4 cCR patients were measurable residual disease (MRD) negative as assessed by local standard of care Early deep responses with SENTI-202 noted across dose levels with all cCRs ongoing as of the data cut and longest durability of 8+ months Company to host webcast to discuss the new Phase 1 SENTI-202 data today, April 28th at 8:30 AM ET; Register Here Announces certain preliminary first quarter 2025 financial results and provides pipeline...

Approval Supports Revenue Growth and Margin Expansion Opportunity, and Substantially Increases Peak Production Output Capacity First U.S. Regulatory Approval of Innovative IG Yield Enhancement Process Highlights ADMA’s Uniquely Efficient Internal R&D Engine, Spanning Production and Product Development Capabilities Anticipate Approximately 20% Production Output Enhancement from Same Starting Plasma Volume The 20% Yield Enhancement Will Benefit Both ASCENIV and BIVIGAM RAMSEY, N.J. and BOCA RATON, Fla., April 28, 2025 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, today announced U.S. FDA approval of its innovative yield enhancement production process. This...

(All dollar amounts are expressed in CAD dollars, unless stated otherwise) HIGHLIGHTS1Robust returns with base case after-tax NPV5% of $943 million, unlevered after-tax IRR of 22.1% and payback2 of 2.8 years at $2,400/oz gold price assumption. Using spot gold price of $3,300/oz, NPV5% improves to $2,066 million, IRR 38.0%, and payback2 of 1.6 years Average annual production of ~190,000 ounces of gold over a 10-year mine life (202,000 ounces in the first 5 years) with first gold anticipated in H2 2027, assuming construction commences in Q3 2025, subject to progress on ongoing project financing discussions Average TCC of US$947/oz and AISC of US$1,157/oz over the LOM, placing the Cariboo Gold Project within the lower half of the global cost curve for gold mines3 Average base case LOM annual FCF of $158 million ($296 million per year in...